Skye Global Management LP Sera Prognostics, Inc. Transaction History

Skye Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.16 - $1.8 $224,459 - $348,300	-193,500 Reduced 36.79%	332,500 $418,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.71 $186,000 - $325,200	120,000 Added 29.56%	526,000 $842,000
Q2 2022 Aug 15, 2022	BUY	$1.2 - $3.62 $1,200 - $3,620	1,000 Added 0.25%	406,000 $666,000
Q1 2022 May 16, 2022	BUY	$2.96 - $8.8 $85,840 - $255,200	29,000 Added 7.71%	405,000 $1.54 Million
Q4 2021 Feb 14, 2022	BUY	$6.87 - $11.41 $137,400 - $228,200	20,000 Added 5.62%	376,000 $2.58 Million
Q3 2021 Nov 15, 2021	BUY	$7.9 - $13.04 $2.81 Million - $4.64 Million	356,000 New	356,000 $3.96 Million

19M

35.4K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $229M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Skye Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Skye Global Management LP with notifications on news.